Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Tamoxifen × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 53 Carcinoma, Intraductal, Noninfiltrating 7 Breast Carcinoma In Situ 5 Neoplasms 3 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Multiple Endocrine Neoplasia Type 1 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hyperglycemia 1 Glioblastoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 ERα+ Breast Cancer 1 Carcinoma, Lobular 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡